Efficacy and Safety of tacalcitol ointment(20mcg/g) in Psoriasis Vulgaris - Double blind inter-group study compared with tacalcitol ointment(2mcg/g)(Study to obtain IDL) -

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080220840

Enrollment

240

Registered

2009-09-03

Start date

2009-09-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis Vulgaris

Interventions

investigational material(s) Generic name etc : Tacalcitol ointment(20mcg/g) INN of investigational material : Tacalcitol monohydrate (INNM) Therapeutic category code : 269 Other agents for epidermis D

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Psoriasis vulgaris

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Efficacy and safety	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026